Skip to main content
Top
Published in: Diabetologia 1/2021

Open Access 01-01-2021 | Type 2 Diabetes | Article

Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study

Authors: Louise Bennet, Ruzan Udumyan, Carl Johan Östgren, Olov Rolandsson, Stefan P. O. Jansson, Per Wändell

Published in: Diabetologia | Issue 1/2021

Login to get access

Abstract

Aims/hypothesis

Non-Western immigrants to Europe are at high risk for type 2 diabetes. In this nationwide study including incident cases of type 2 diabetes, the aim was to compare all-cause mortality (ACM) and cause-specific mortality (CSM) rates in first- and second-generation immigrants with native Swedes.

Methods

People living in Sweden diagnosed with new-onset pharmacologically treated type 2 diabetes between 2006 and 2012 were identified through the Swedish Prescribed Drug Register. They were followed until 31 December 2016 for ACM and until 31 December 2012 for CSM. Analyses were adjusted for age at diagnosis, sex, socioeconomic status, education, treatment and region. Associations were assessed using Cox regression analysis.

Results

In total, 138,085 individuals were diagnosed with type 2 diabetes between 2006 and 2012 and fulfilled inclusion criteria. Of these, 102,163 (74.0%) were native Swedes, 28,819 (20.9%) were first-generation immigrants and 7103 (5.1%) were second-generation immigrants with either one or both parents born outside Sweden. First-generation immigrants had lower ACM rate (HR 0.80 [95% CI 0.76, 0.84]) compared with native Swedes. The mortality rates were particularly low in people born in non-Western regions (0.46 [0.42, 0.50]; the Middle East, 0.41 [0.36, 0.47]; Asia, 0.53 [0.43, 0.66]; Africa, 0.47 [0.38, 0.59]; and Latin America, 0.53 [0.42, 0.68]). ACM rates decreased with older age at migration and shorter stay in Sweden. Compared with native Swedes, first-generation immigrants with ≤ 24 years in Sweden (0.55 [0.51, 0.60]) displayed lower ACM rates than those spending >24 years in Sweden (0.92 [0.87, 0.97]). Second-generation immigrants did not have better survival rates than native Swedes but rather displayed higher ACM rates for people with both parents born abroad (1.28 [1.05, 1.56]).

Conclusions/interpretation

In people with type 2 diabetes, the lower mortality rate in first-generation non-Western immigrants compared with native Swedes was reduced over time and was equalised in second-generation immigrants. These findings suggest that acculturation to Western culture may impact ACM and CSM in immigrants with type 2 diabetes but further investigation is needed.
Appendix
Available only for authorised users
Literature
13.
go back to reference Wallace M, Khlat M, Guillot M (2019) Mortality advantage among migrants according to duration of stay in France, 2004–2014. BMC Public Health 19(1):327CrossRefPubMedPubMedCentral Wallace M, Khlat M, Guillot M (2019) Mortality advantage among migrants according to duration of stay in France, 2004–2014. BMC Public Health 19(1):327CrossRefPubMedPubMedCentral
14.
go back to reference Vandenheede H, Willaert D, De Grande H, Simoens S, Vanroelen C (2015) Mortality in adult immigrants in the 2000s in Belgium: A test of the 'healthy-migrant' and the 'migration-as-rapid-health-transition' hypotheses. Tropical Med Int Health 20(12):1832–1845CrossRef Vandenheede H, Willaert D, De Grande H, Simoens S, Vanroelen C (2015) Mortality in adult immigrants in the 2000s in Belgium: A test of the 'healthy-migrant' and the 'migration-as-rapid-health-transition' hypotheses. Tropical Med Int Health 20(12):1832–1845CrossRef
15.
go back to reference Syse A, Dzamarija MT, Kumar BN, Diaz E (2018) An observational study of immigrant mortality differences in Norway by reason for migration, length of stay and characteristics of sending countries. BMC Public Health 18(1):508CrossRefPubMedPubMedCentral Syse A, Dzamarija MT, Kumar BN, Diaz E (2018) An observational study of immigrant mortality differences in Norway by reason for migration, length of stay and characteristics of sending countries. BMC Public Health 18(1):508CrossRefPubMedPubMedCentral
16.
go back to reference Wettermark B, Hammar N, Fored CM et al (2007) The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726–735CrossRefPubMed Wettermark B, Hammar N, Fored CM et al (2007) The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726–735CrossRefPubMed
21.
go back to reference Royston P, Sauerbrei W (2005) Building multivariable regression models with continuous covariates in clinical epidemiology—With an emphasis on fractional polynomials. Methods Inf Med 44(4):561–571CrossRefPubMed Royston P, Sauerbrei W (2005) Building multivariable regression models with continuous covariates in clinical epidemiology—With an emphasis on fractional polynomials. Methods Inf Med 44(4):561–571CrossRefPubMed
27.
go back to reference Tran AT, Berg TJ, Gjelsvik B et al (2019) Ethnic and gender differences in the management of type 2 diabetes: A cross-sectional study from Norwegian general practice. BMC Health Serv Res 19(1):904CrossRefPubMedPubMedCentral Tran AT, Berg TJ, Gjelsvik B et al (2019) Ethnic and gender differences in the management of type 2 diabetes: A cross-sectional study from Norwegian general practice. BMC Health Serv Res 19(1):904CrossRefPubMedPubMedCentral
33.
go back to reference Lyssenko V, Almgren P, Anevski D et al (2005) Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54(1):166–174CrossRefPubMed Lyssenko V, Almgren P, Anevski D et al (2005) Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 54(1):166–174CrossRefPubMed
40.
Metadata
Title
Mortality in first- and second-generation immigrants to Sweden diagnosed with type 2 diabetes: a 10 year nationwide cohort study
Authors
Louise Bennet
Ruzan Udumyan
Carl Johan Östgren
Olov Rolandsson
Stefan P. O. Jansson
Per Wändell
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Keyword
Type 2 Diabetes
Published in
Diabetologia / Issue 1/2021
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-020-05279-1

Other articles of this Issue 1/2021

Diabetologia 1/2021 Go to the issue

Up Front

Up front

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.